Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2005 Feb;97(2):197–205.

The 894T allele of endothelial nitric oxide synthase gene is related to left ventricular mass in African Americans with high-normal blood pressure.

Rigobert Lapu-Bula 1, Alexander Quarshie 1, Deborah Lyn 1, Adefisayo Oduwole 1, Cheryl Pack 1, Jan Morgan 1, Sunday Nkemdiche 1, Priscilla Igho-Pemu 1, Anekwe Onwuanyi 1, Rongling Li 1, Elizabeth Ofili 1
PMCID: PMC2568802  PMID: 15712782

Abstract

BACKGROUND AND OBJECTIVES: The 894T allele in exon 7 of the endothelial nitric oxide synthase (eNOS) gene has been inconsistently associated with hypertension in different racial groups. Because high-normal blood pressure (BP) confers an increased risk for the development of hypertension and other cardiovascular disorders, including left ventricular hypertrophy (LVH), we tested the hypothesis that the allelic variation (894T) in the eNOS gene would directly correlate with alterations in LV mass (LVM) in individuals with high-normal BP. METHODS: Genotype distribution of G894T was compared between 20 African Americans (10 females/10 males) with high-normal BP (systolic BP of 130-139 and/or diastolic BP of 85-89 mmHg) and 64 counterparts (37 females/27 males) with normal BP (<130/85 mmHg). Echocardiographic LVM was calculated (Devereux formula) and indexed to body surface area to define the presence of LVH (LVMI >134/110 g/m2 for men/women). RESULTS: For the entire group, the 894T allelic frequencies (15, 48%) and G894T genotype distributions were consistent with the Hardy-Weinberg equilibrium expectations (estimated disequilibrium coefficient = 0.0118, P=0.40). LVMI was significantly higher in homozygous carriers (TT) of the rare 894T allele (n = 3 females/0 males) than in heterozygous GT (n = 13 females/7 males) and individuals bearing the GG (n=34 females/27 males) variant (124 +/- 70 vs. 82 +/- 24 and 82 +/- 19 g/m2, respectively, P < 0.05). The observed relationship between eNOS 894T allele and LVMI was restricted to individuals with high-normal BP (r = 0.94, P = 0.03) but not in those with normal BP (r = 0.39, P =0.64), by analysis of variance (ANOVA) after adjusting for age, gender, body mass index, smoking and systolic BP. CONCLUSION: These findings, not previously described, provide important preliminary evidence to suggest an increased susceptibility to LVH in African Americans who carry the 894T variant of the eNOS gene and have high-normal blood pressure.

Full text

PDF
197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams T. D., Yanowitz F. G., Fisher A. G., Ridges J. D., Nelson A. G., Hagan A. D., Williams R. R., Hunt S. C. Heritability of cardiac size: an echocardiographic and electrocardiographic study of monozygotic and dizygotic twins. Circulation. 1985 Jan;71(1):39–44. doi: 10.1161/01.cir.71.1.39. [DOI] [PubMed] [Google Scholar]
  2. Aeschbacher B. C., Hutter D., Fuhrer J., Weidmann P., Delacrétaz E., Allemann Y. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens. 2001 Feb;14(2):106–113. doi: 10.1016/s0895-7061(00)01245-0. [DOI] [PubMed] [Google Scholar]
  3. Arnett D. K., Hong Y., Bella J. N., Oberman A., Kitzman D. W., Hopkins P. N., Rao D. C., Devereux R. B. Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study. Hypertension Genetic Epidemiology Network. Am J Hypertens. 2001 Dec;14(12):1226–1230. doi: 10.1016/s0895-7061(01)02200-2. [DOI] [PubMed] [Google Scholar]
  4. Boddi M., Poggesi L., Coppo M., Zarone N., Sacchi S., Tania C., Neri Serneri G. G. Human vascular renin-angiotensin system and its functional changes in relation to different sodium intakes. Hypertension. 1998 Mar;31(3):836–842. doi: 10.1161/01.hyp.31.3.836. [DOI] [PubMed] [Google Scholar]
  5. Campese V. M., Tawadrous M., Bigazzi R., Bianchi S., Mann A. S., Oparil S., Raij L. Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. Hypertension. 1996 Sep;28(3):335–340. doi: 10.1161/01.hyp.28.3.335. [DOI] [PubMed] [Google Scholar]
  6. Chen W., Srinivasan S. R., Elkasabany A., Ellsworth D. L., Boerwinkle E., Berenson G. S. Combined effects of endothelial nitric oxide synthase gene polymorphism (G894T) and insulin resistance status on blood pressure and familial risk of hypertension in young adults: the Bogalusa Heart Study. Am J Hypertens. 2001 Oct;14(10):1046–1052. doi: 10.1016/s0895-7061(01)02192-6. [DOI] [PubMed] [Google Scholar]
  7. Chobanian Aram V., Bakris George L., Black Henry R., Cushman William C., Green Lee A., Izzo Joseph L., Jr, Jones Daniel W., Materson Barry J., Oparil Suzanne, Wright Jackson T., Jr The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 14;289(19):2560–2572. doi: 10.1001/jama.289.19.2560. [DOI] [PubMed] [Google Scholar]
  8. Devereux R. B., Alonso D. R., Lutas E. M., Gottlieb G. J., Campo E., Sachs I., Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986 Feb 15;57(6):450–458. doi: 10.1016/0002-9149(86)90771-x. [DOI] [PubMed] [Google Scholar]
  9. Devereux R. B., de Simone G., Koren M. J., Roman M. J., Laragh J. H. Left ventricular mass as a predictor of development of hypertension. Am J Hypertens. 1991 Nov;4(11):603S–607S. doi: 10.1093/ajh/4.11s.603s. [DOI] [PubMed] [Google Scholar]
  10. Devlin A. M., Brosnan M. J., Graham D., Morton J. J., McPhaden A. R., McIntyre M., Hamilton C. A., Reid J. L., Dominiczak A. F. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. Am J Physiol. 1998 Jan;274(1 Pt 2):H52–H59. doi: 10.1152/ajpheart.1998.274.1.H52. [DOI] [PubMed] [Google Scholar]
  11. Douglas Janice G., Bakris George L., Epstein Murray, Ferdinand Keith C., Ferrario Carlos, Flack John M., Jamerson Kenneth A., Jones Wendell E., Haywood Julian, Maxey Randall. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003 Mar 10;163(5):525–541. doi: 10.1001/archinte.163.5.525. [DOI] [PubMed] [Google Scholar]
  12. Dubey R. K., Boegehold M. A., Gillespie D. G., Rosselli M. Increased nitric oxide activity in early renovascular hypertension. Am J Physiol. 1996 Jan;270(1 Pt 2):R118–R124. doi: 10.1152/ajpregu.1996.270.1.R118. [DOI] [PubMed] [Google Scholar]
  13. Garner C., Lecomte E., Visvikis S., Abergel E., Lathrop M., Soubrier F. Genetic and environmental influences on left ventricular mass. A family study. Hypertension. 2000 Nov;36(5):740–746. doi: 10.1161/01.hyp.36.5.740. [DOI] [PubMed] [Google Scholar]
  14. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982 Oct;126(1):131–138. doi: 10.1016/0003-2697(82)90118-x. [DOI] [PubMed] [Google Scholar]
  15. Haffner S. M., Ferrannini E., Hazuda H. P., Stern M. P. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension. 1992 Jul;20(1):38–45. doi: 10.1161/01.hyp.20.1.38. [DOI] [PubMed] [Google Scholar]
  16. Harshfield G. A., Grim C. E., Hwang C., Savage D. D., Anderson S. J. Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins. Am J Hypertens. 1990 Jul;3(7):538–543. doi: 10.1093/ajh/3.7.538. [DOI] [PubMed] [Google Scholar]
  17. Hayakawa H., Raij L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension. 1997 Jan;29(1 Pt 2):235–241. doi: 10.1161/01.hyp.29.1.235. [DOI] [PubMed] [Google Scholar]
  18. Kannel William B., Vasan Ramachandran S., Levy Daniel. Is the relation of systolic blood pressure to risk of cardiovascular disease continuous and graded, or are there critical values? Hypertension. 2003 Sep 15;42(4):453–456. doi: 10.1161/01.HYP.0000093382.69464.C4. [DOI] [PubMed] [Google Scholar]
  19. Karvonen J., Kauma H., Kervinen K., Rantala M., Ikäheimo M., Päivänsalo M., Savolainen M. J., Kesäniemi Y. A. Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med. 2002 Feb;251(2):102–110. doi: 10.1046/j.1365-2796.2002.00933.x. [DOI] [PubMed] [Google Scholar]
  20. Kato N., Sugiyama T., Morita H., Nabika T., Kurihara H., Yamori Y., Yazaki Y. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension. 1999 Apr;33(4):933–936. doi: 10.1161/01.hyp.33.4.933. [DOI] [PubMed] [Google Scholar]
  21. Kimura Y., Tomiyama H., Nishikawa E., Watanabe G., Shiojima K., Nakayama T., Yoshida H., Kuwata S., Kinouchi T., Doba N. Characteristics of cardiovascular morphology and function in the high-normal subset of hypertension defined by JNC-VI recommendations. Hypertens Res. 1999 Nov;22(4):291–295. doi: 10.1291/hypres.22.291. [DOI] [PubMed] [Google Scholar]
  22. Koren M. J., Devereux R. B., Casale P. N., Savage D. D., Laragh J. H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991 Mar 1;114(5):345–352. doi: 10.7326/0003-4819-114-5-345. [DOI] [PubMed] [Google Scholar]
  23. Lapu-Bula R., Robert A., De Kock M., D'Hondt A. M., Detry J. M., Melin J. A., Vanoverschelde J. L. Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol. 1999 Mar 1;83(5):728–734. doi: 10.1016/s0002-9149(98)00979-5. [DOI] [PubMed] [Google Scholar]
  24. Lauer M. S., Anderson K. M., Larson M. G., Levy D. A new method for indexing left ventricular mass for differences in body size. Am J Cardiol. 1994 Sep 1;74(5):487–491. doi: 10.1016/0002-9149(94)90909-1. [DOI] [PubMed] [Google Scholar]
  25. Leeson C. P. M., Hingorani A. D., Mullen M. J., Jeerooburkhan N., Kattenhorn M., Cole T. J., Muller D. P. R., Lucas A., Humphries S. E., Deanfield J. E. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res. 2002 Jun 14;90(11):1153–1158. doi: 10.1161/01.res.0000020562.07492.d4. [DOI] [PubMed] [Google Scholar]
  26. Leitschuh M., Cupples L. A., Kannel W., Gagnon D., Chobanian A. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension. 1991 Jan;17(1):22–27. doi: 10.1161/01.hyp.17.1.22. [DOI] [PubMed] [Google Scholar]
  27. Levy D., Garrison R. J., Savage D. D., Kannel W. B., Castelli W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990 May 31;322(22):1561–1566. doi: 10.1056/NEJM199005313222203. [DOI] [PubMed] [Google Scholar]
  28. Liao Y., Cooper R. S., McGee D. L., Mensah G. A., Ghali J. K. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA. 1995 May 24;273(20):1592–1597. [PubMed] [Google Scholar]
  29. Liebson P. R., Grandits G., Prineas R., Dianzumba S., Flack J. M., Cutler J. A., Grimm R., Stamler J. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1993 Feb;87(2):476–486. doi: 10.1161/01.cir.87.2.476. [DOI] [PubMed] [Google Scholar]
  30. Mo R., Nordrehaug J. E., Omvik P., Lund-Johansen P. The Bergen Blood Pressure Study: prehypertensive changes in cardiac structure and function in offspring of hypertensive families. Blood Press. 1995 Jan;4(1):16–22. doi: 10.3109/08037059509077563. [DOI] [PubMed] [Google Scholar]
  31. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens. 1996 Jan;9(1):1–11. doi: 10.1016/0895-7061(95)00341-x. [DOI] [PubMed] [Google Scholar]
  32. Port S., Demer L., Jennrich R., Walter D., Garfinkel A. Systolic blood pressure and mortality. Lancet. 2000 Jan 15;355(9199):175–180. doi: 10.1016/S0140-6736(99)07051-8. [DOI] [PubMed] [Google Scholar]
  33. Post W. S., Larson M. G., Myers R. H., Galderisi M., Levy D. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension. 1997 Nov;30(5):1025–1028. doi: 10.1161/01.hyp.30.5.1025. [DOI] [PubMed] [Google Scholar]
  34. Schillaci G., Verdecchia P., Porcellati C., Cuccurullo O., Cosco C., Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000 Feb;35(2):580–586. doi: 10.1161/01.hyp.35.2.580. [DOI] [PubMed] [Google Scholar]
  35. Schmieder R. E., Messerli F. H., Garavaglia G. E., Nunez B. D. Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation. 1988 Oct;78(4):951–956. doi: 10.1161/01.cir.78.4.951. [DOI] [PubMed] [Google Scholar]
  36. Schunkert H., Bröckel U., Hengstenberg C., Luchner A., Muscholl M. W., Kurzidim K., Kuch B., Döring A., Riegger G. A., Hense H. W. Familial predisposition of left ventricular hypertrophy. J Am Coll Cardiol. 1999 May;33(6):1685–1691. doi: 10.1016/s0735-1097(99)00050-9. [DOI] [PubMed] [Google Scholar]
  37. Sherif K., Barrett M., Kushner H., Falkner B. The association of left ventricular mass with cardiovascular risk factors in African American women. Am J Med Sci. 2000 Jul;320(1):13–17. doi: 10.1097/00000441-200007000-00003. [DOI] [PubMed] [Google Scholar]
  38. Simko F., Simko J. The potential role of nitric oxide in the hypertrophic growth of the left ventricle. Physiol Res. 2000;49(1):37–46. [PubMed] [Google Scholar]
  39. Stamler R., Stamler J., Gosch F. C., Civinelli J., Fishman J., McKeever P., McDonald A., Dyer A. R. Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial. JAMA. 1989 Oct 6;262(13):1801–1807. [PubMed] [Google Scholar]
  40. Tanus-Santos J. E., Desai M., Flockhart D. A. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 2001 Nov;11(8):719–725. doi: 10.1097/00008571-200111000-00011. [DOI] [PubMed] [Google Scholar]
  41. Vasan R. S., Larson M. G., Leip E. P., Evans J. C., O'Donnell C. J., Kannel W. B., Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001 Nov 1;345(18):1291–1297. doi: 10.1056/NEJMoa003417. [DOI] [PubMed] [Google Scholar]
  42. Vasan R. S., Larson M. G., Leip E. P., Kannel W. B., Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001 Nov 17;358(9294):1682–1686. doi: 10.1016/S0140-6736(01)06710-1. [DOI] [PubMed] [Google Scholar]
  43. Verhaaren H. A., Schieken R. M., Mosteller M., Hewitt J. K., Eaves L. J., Nance W. E. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study). Am J Cardiol. 1991 Sep 1;68(6):661–668. doi: 10.1016/0002-9149(91)90361-n. [DOI] [PubMed] [Google Scholar]
  44. Wang X. L., Mahaney M. C., Sim A. S., Wang J., Wang J., Blangero J., Almasy L., Badenhop R. B., Wilcken D. E. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3147–3153. doi: 10.1161/01.atv.17.11.3147. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES